NCT06474650

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

A Randomized, Open-label, Two-period, Double-crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Luye Pharma Group Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a A single-center, randomized, open-label, two-dose, two-period, crossover trial was conducted to evaluate the effect of food on the Pharmacokinetic characteristics and safety of oral administration of LPM3770164 sustained-release tablets 30 mg in healthy subjects.

Conditions

• Huntington Disease
• Tardive Dyskinesia

Interventions

Type	Name	Description
DRUG	LPM3770164 sustained release tablet	Single-dose of 30 mg of LPM3770164 sustained release tablet

Timeline

• Start date: 2024-07-31
• Primary completion: 2024-09-25
• Completion: 2024-09-25
• First posted: 2024-06-25
• Last updated: 2024-12-12

Locations

1 site across 1 country: China